## CL: Colgate-Palmolive Company - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 0.1% below STRENGTH zone (3.0-6.0%); PEG 3.00 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($76.16)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Who Owns Colgate-Palmolive? Top Shareholders and Recent Insider Trades**
- Source: TIKR.com | 20251222T150839 | Neutral | Relevance: 100%
- This article details the top institutional shareholders of Colgate-Palmolive (NYSE: CL) and recent insider trading activity. It highlights that major institutional investors, particularly passive managers, dominate ownership, while active managers show mixed positions. Insider transactions lean towards minor selling, which doesn't indicate aggressive sentiment but rather a measured approach to current valuation.

**2. Legacy Wealth Asset Management LLC Has $1.89 Million Position in Colgate-Palmolive Company $CL**
- Source: MarketBeat | 20251222T120803 | Somewhat-Bullish | Relevance: 100%
- Legacy Wealth Asset Management LLC significantly increased its stake in Colgate-Palmolive Company (NYSE:CL) during Q3, now owning 23,612 shares valued at $1.89 million. Analysts maintain a "Moderate Buy" consensus for Colgate-Palmolive, with an average price target of $88.81. The company also declared a quarterly dividend of $0.52 per share, with an ex-dividend date of January 21st.

**3. Colgate-Palmolive Company $CL Stock Holdings Raised by Exchange Traded Concepts LLC**
- Source: MarketBeat | 20251222T100812 | Somewhat-Bullish | Relevance: 100%
- Exchange Traded Concepts LLC increased its stake in Colgate-Palmolive Company (NYSE:CL) by 15% in Q3, now owning 400,137 shares valued at $31.99 million. Institutional investors and hedge funds collectively own 80.41% of the stock. Colgate-Palmolive recently reported Q3 earnings of $0.91 per share, beating estimates, and declared a quarterly dividend of $0.52 per share with an ex-dividend date of January 21st.

**4. Colgate-Palmolive Company $CL Shares Purchased by Sarasin & Partners LLP**
- Source: MarketBeat | 20251221T133343 | Somewhat-Bullish | Relevance: 100%
- Sarasin & Partners LLP increased its stake in Colgate-Palmolive Company (NYSE:CL) by 2.5% in the third quarter, making it their 8th largest holding. Other institutional investors like Vanguard Group Inc. and Norges Bank also significantly increased their positions in CL. Despite some trimmed price targets from analysts, the consensus rating remains a "Moderate Buy" with an average target price of $88.81.

**5. Osaic Holdings Inc. Has $12.80 Million Holdings in Colgate-Palmolive Company $CL**
- Source: MarketBeat | 20251220T111603 | Somewhat-Bullish | Relevance: 100%
- Osaic Holdings Inc. significantly increased its stake in Colgate-Palmolive (NYSE:CL) by 18.8% in Q2, now holding 140,666 shares valued at approximately $12.80 million. The stock maintains a "Moderate Buy" consensus rating with an average target price of $88.81 despite recent price target trims by some brokerages. Colgate-Palmolive reported Q2 EPS of $0.91, exceeding estimates, and declared a quarterly dividend of $0.52 (2.6% yield), with a market cap of about $63.3 billion.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | JP Morgan | $88 | $87 | +1% |
| 2025-12-11 | Argus Research | $0 | $0 | 0% |
| 2025-12-09 | RBC Capital | $88 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | JP Morgan | main | Overweight |
| 2025-12-11 | Argus Research | down | Hold |
| 2025-12-09 | RBC Capital | up | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.07M) |
| Sells | 7 ($0.28M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.3% (+0.2%)
- Blackrock Inc.: 8.6% (+0.5%)
- State Street Corpora: 6.0% (+0.2%)
- Price (T.Rowe) Assoc: 4.0% (-11.5%)
- Geode Capital Manage: 2.7% (+4.1%)

### Key Risks

1. Valuation stretched: PEG 3.0x requires aggressive growth execution.
2. Long-term trend broken: trading 7.7% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.00 signals overvaluation risk, limited margin of safety. Forward P/E 20.6x stretched relative to 5% growth. Quality metrics strong (ROE 294%, ROA 15%). Balance sheet: $1.1B free cash flow. Institutional flow bearish (5 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $63.9B |
| Beta | 0.29 |
| 52W Range | $74.55 - $100.18 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.00 |
| Forward P/E | 20.6 |
| Current P/E | 21.6 |
| YoY Growth | 5.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 2.8% to 0.1% (-2.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.9pp (needs >3.0% for momentum thesis). MRS_5 (-1.1%) diverging from MRS_10 - short-term weakness emerging. Below SMA200 (0.92x), long-term trend not supportive. RSI neutral at 52. OFD pattern: +FTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.08% (CS: 53) | Neutral |
| RSI_14 | 52.1 | Neutral |
| MACD Histogram | 0.07 | Bullish |
| vs SMA20 | 1.005x | Above |
| vs SMA50 | 1.009x | Above |
| vs SMA200 | 0.923x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $79.00
- **Stop Loss:** $76.16 (3.6% risk)
- **Target:** $81.84 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 211
- **Position Value:** $16,669.00
- **Portfolio %:** 16.67%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-01-30 (Est: $0.91)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.89 | $0.91 | +2.4% |
| 2025Q2 | $0.89 | $0.92 | +2.8% |
| 2025Q1 | $0.86 | $0.91 | +6.1% |
| 2024Q4 | $0.89 | $0.91 | +2.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*